[Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
There was the evaluation of circulating T-cells with the help of the E-rosette-assay in patients with breast cancer (n = 52), carcinoma of the cervix uteri (n = 29), carcinoma of the endometrium (n = 32) and carcinoma of the ovary (n = 7). Twenty seven healthy female blood donors were used as control group. There was no statistically significant difference between the total and active E-rosette values of the patients with tumours and the control group. Patients with breast cancer pT1N0 had significant lower total E-rosette values (Gpt/l) than patients with higher tumour stadium (p less than 0.05). The white blood cell count showed a statistically significant leucocytosis in cancer patient groups versus control persons (p less than 0.05).
Strache
R R
RR
Frauenklinik des Bezirkskrankenhauses, Wismar.
Büttner
H H
HH
Kunze
M
M
Röpcke
G
G
D000293:Adolescent; D000328:Adult; D001943:Breast Neoplasms / Q000276:immunology* / Q000473:pathology; D005260:Female; D005833:Genital Neoplasms, Female / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000276:immunology; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
Zirkulierende T-Zellen bei Patientinnen mit Mamma- oder Genitalkarzinomen in der prätherapeutischen Phase.